Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;35(1):239-244.
doi: 10.1038/s41375-020-0799-8. Epub 2020 Mar 18.

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

Tait D Shanafelt  1 , Neil E Kay  2 , Sameer A Parikh  2 , Sara J Achenbach  2 , Connie E Lesnick  2 , Curtis A Hanson  2 , Geffen Kleinstern  2 , Janet E Olson  2 , Aaron D Norman  2 , Kari G Rabe  2 , Susan M Schwager  2 , Timothy G Call  2 , Susan L Slager  2
Affiliations

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

Tait D Shanafelt et al. Leukemia. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards

Conflict of interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Clinical outcomes of individuals with monoclonal B-cell lymphocytosis (MBL) compared to those without MBL.
a Cumulative incidence of hospitalization for infection among individuals with (n = 106) and without MBL (n = 865) adjusted for age and sex. b Overall survival among individuals with (n = 106) and without MBL (n = 865) adjusted for age and sex.
See this image and copyright information in PMC

References

    1. Rawstron A, Green M, Kuzmicki A, Kennedy B, Fenton J, Evans P, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635–9. - PubMed
    1. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512–20. - PMC - PubMed
    1. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A, et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytom Part B, Clin Cytom. 2010;78 Suppl 1:S19–23. - PMC - PubMed
    1. Moreira J, Rabe KG, Cerhan JR, Kay NE, Wilson JW, Call TG, et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia. 2013;27:136–41. - PubMed
    1. Fazi C, Scarfo L, Pecciarini L, Cottini F, Dagklis A, Janus A, et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood. 2011;118:6618–25. - PubMed

Publication types